WallStreetZenWallStreetZen

NASDAQ: ADXN
Addex Therapeutics Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ADXN stock forecasts and price targets.

Forecast return on equity

Is ADXN forecast to generate an efficient return?

Forecast return on assets

Is ADXN forecast to generate an efficient return on assets?

ADXN revenue forecast

What is ADXN's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$3.2M+61.16%

ADXN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADXN$15.41N/AN/A
AVTX$14.98$35.00+133.64%Buy
COCP$1.51$10.00+562.25%Buy
VAXX$0.12N/AN/A
CDIO$0.72$1.35+86.98%Buy

Addex Therapeutics Stock Forecast FAQ

What is ADXN's revenue growth forecast for 2024-2024?

(NASDAQ: ADXN) Addex Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Addex Therapeutics's revenue in 2024 is $1,830,076.

In 2024, ADXN is forecast to generate $395,617,442 in revenue, with the lowest revenue forecast at $395,617,442 and the highest revenue forecast at $395,617,442.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.

What is ADXN's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: ADXN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.61%.

What is ADXN's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: ADXN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.